RINGSIDE: A phase 3 randomized, placebo-controlled trial of varegacestat for treatment of progressing desmoid tumors.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Mrinal M. Gounder, Piotr Rutkowski, Robin L. Jones, Atrayee Basu Mallick, Nam Bui, Rashmi Chugh, Lara E. Davis, Hyo Song Kim, Javier Martin Broto, Elena Palassini, Ravin Ratan, Arun S. Singh, Nimit Singhal, Winette T.A. Van Der Graaf, Alona Zer, Matthew Birrenkott, Katie Newhall, Eric Song, Jonathan Yovell, Bernd Kasper
Institutions: Memorial Sloan Kettering Cancer Center, The Maria Sklodowska-Curie National Research Institute of Oncology, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Thomas Jefferson University, Stanford Health Care, University of Michigan, Oregon Health & Science University, Yonsei University, Hospital Universitario Fundación Jiménez Díaz, The University of Texas MD Anderson Cancer Center, University of California, Los Angeles, The Netherlands Cancer Institute, Rambam Health Care Campus, University of Mannheim, University Medical Centre Mannheim
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162492430